PhRMA names four members of its review panel on DTC

Share this article:
PhRMA named four members of its Guiding Principles independent review panel on DTC: Lawrence “L.B.” Brown, PhD, PharmD, University of Tennessee Department of Pharmaceutical Sciences; James Jones, MD, East Carolina University School of Medicine; Nancy Sharp, MSN, RN, FAAN, former head of the American College of Nurse Practitioners; and Lucille Perez, MD, 102nd president of the National Medical Association. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.